Home
HomeChat
Markets
AlertsCalendarScreenerCharts
Portfolio
WatchlistsPortfolioFiles
Account
Docs
Sign upJoinLog inLogin

Cryo-Cell International, Inc. (CCEL) stock profile

Cryo-Cell International, Inc. specializes in cellular processing and cryogenic storage, focusing on the collection and preservation of umbilical cord blood stem cells for family use. The company provides cord tissue services that store sections of the umbilical cord tissue, a source of mesenchymal stem cells used in regenerative medicine to treat conditions including heart and kidney disease, ALS, wound healing, and autoimmune diseases. Cryo-Cell also manufactures and sells the PrepaCyte CB processing system, a technology used to process umbilical cord blood stem cells. It stores approximately 500,000 cord blood and cord tissue stem cells worldwide. The company markets its cord blood stem cell preservation services directly to expectant parents and through obstetricians, pediatricians, childbirth educators, certified nurse-midwives, and other healthcare professionals. Cryo-Cell International was incorporated in 1989 and is headquartered in Oldsmar, Florida.

Key facts

SymbolCCEL
ExchangeAMEX
SectorHealthcare
IndustryMedical - Care Facilities
CEODavid Portnoy
Employees73
HeadquartersOldsmar, FL, US
IPO1994-04-04
Websitewww.cryo-cell.com

Explore CCEL on Vantafin

  • Cryo-Cell International, Inc. Overview
  • Cryo-Cell International, Inc. Financials
  • Cryo-Cell International, Inc. News
  • Cryo-Cell International, Inc. Events
  • Cryo-Cell International, Inc. SEC filings
  • Cryo-Cell International, Inc. Insider transactions

Frequently asked questions

What does Cryo-Cell International, Inc. (CCEL) do?
Cryo-Cell International, Inc. specializes in cellular processing and cryogenic storage, focusing on the collection and preservation of umbilical cord blood stem cells for family use. The company provides cord tissue services that store sections of the umbilical cord tissue, a source of mesenchymal stem cells used in regenerative medicine to treat conditions including heart and kidney disease, ALS, wound healing, and autoimmune diseases. Cryo-Cell also manufactures and sells the PrepaCyte CB processing system, a technology used to process umbilical cord blood stem cells. It stores approximately 500,000 cord blood and cord tissue stem cells worldwide. The company markets its cord blood stem cell preservation services directly to expectant parents and through obstetricians, pediatricians, childbirth educators, certified nurse-midwives, and other healthcare professionals. Cryo-Cell International was incorporated in 1989 and is headquartered in Oldsmar, Florida.
Where is CCEL stock listed?
Cryo-Cell International, Inc. trades under the ticker CCEL on AMEX.
How can I research CCEL's financials and filings?
Vantafin provides Cryo-Cell International, Inc.'s income statement, balance sheet and cash-flow data, SEC filings, earnings-call transcripts, and insider & institutional ownership on the CCEL profile.